Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

HRTX | Heron Therapeutics Inc

IndexRUT P/E- EPS (ttm)-1.17 Insider Own1.33% Shs Outstand140.76M Perf Week-14.69%
Market Cap138.10M Forward P/E- EPS next Y-0.59 Insider Trans132.83% Shs Float138.88M Perf Month-41.60%
Income-136.60M PEG- EPS next Q-0.27 Inst Own82.46% Short Float / Ratio18.23% / 13.30 Perf Quarter-13.18%
Sales117.96M P/S1.17 EPS this Y35.21% Inst Trans5.82% Short Interest25.32M Perf Half Y-48.50%
Book/sh-0.33 P/B- EPS next Y45.70% ROA-61.37% Target Price7.92 Perf Year-77.24%
Cash/sh0.24 P/C4.15 EPS next 5Y23.14% ROE-2408.88% 52W Range0.99 - 4.68 Perf YTD-60.76%
Dividend- P/FCF- EPS past 5Y14.46% ROI-119.55% 52W High-79.04% Beta1.06
Dividend %- Quick Ratio1.39 Sales past 5Y44.61% Gross Margin45.44% 52W Low-1.28% ATR0.10
Employees203 Current Ratio1.91 Sales Q/Q14.95% Oper. Margin-116.74% RSI (14)24.13 Volatility7.45% 6.96%
OptionableYes Debt/Eq- EPS Q/Q36.17% Profit Margin-115.80% Rel Volume1.78 Prev Close1.01
ShortableYes LT Debt/Eq- EarningsAug 14 AMC Payout- Avg Volume1.90M Price0.98
Recom1.00 SMA20-27.74% SMA50-34.30% SMA200-50.49% Volume3,386,780 Change-2.86%
Date Action Analyst Rating Change Price Target Change
May-27-20Initiated Guggenheim Buy $24
Feb-20-20Reiterated Needham Buy $50 → $48
Jan-16-19Reiterated Needham Buy $66 → $64
Apr-05-18Initiated Evercore ISI Outperform $56
Mar-19-18Reiterated Mizuho Buy $28 → $35
Mar-01-18Reiterated Needham Buy $28 → $30
Jan-03-18Initiated Leerink Partners Outperform $22
Sep-27-17Initiated Northland Capital Outperform $40
Feb-27-17Initiated Needham Buy $28
Oct-26-16Initiated Aegis Capital Buy
Aug-07-14Initiated Noble Financial Buy $18
Aug-24-23 09:29AM
Aug-15-23 01:30PM
12:48PM
09:47AM
Aug-14-23 04:29PM
04:05PM Loading…
04:05PM
Aug-07-23 04:05PM
10:50AM
Jul-26-23 01:30PM
Jul-24-23 09:02AM
09:00AM
Jun-23-23 04:05PM
Jun-12-23 09:00AM
May-11-23 05:15PM
04:12PM
04:01PM Loading…
04:01PM
May-05-23 12:28PM
Apr-20-23 11:45AM
09:00AM
Apr-17-23 04:05PM
Apr-06-23 03:42PM
02:01PM
Apr-03-23 09:00AM
Mar-27-23 07:12AM
Mar-24-23 06:43AM
Mar-23-23 09:28PM
05:35PM
04:05PM
Mar-13-23 09:00AM
Mar-10-23 04:05PM
09:00AM Loading…
Mar-06-23 09:00AM
Feb-27-23 04:30PM
Feb-22-23 09:00AM
Jan-30-23 05:54AM
Jan-09-23 08:30AM
Dec-29-22 09:45AM
09:00AM
Dec-28-22 12:32PM
Dec-20-22 03:41PM
Nov-21-22 04:05PM
Nov-15-22 10:14PM
Nov-10-22 05:44AM
Nov-09-22 01:15PM
Nov-08-22 06:25PM
04:05PM
Nov-04-22 11:48AM
Nov-01-22 04:05PM
Sep-26-22 09:45AM
Sep-23-22 09:19AM
07:30AM
Sep-19-22 06:42AM
Sep-16-22 02:49PM
Sep-12-22 07:37AM
Aug-23-22 12:00PM
Aug-15-22 09:55AM
Aug-09-22 02:10PM
09:15AM
08:01AM
08:00AM
Aug-02-22 04:05PM
Jul-21-22 06:32AM
Jul-18-22 06:00PM
Jun-30-22 08:41AM
08:30AM
Jun-14-22 08:30AM
May-26-22 04:05PM
May-16-22 04:05PM
May-09-22 06:45PM
04:05PM
May-03-22 04:05PM
Apr-05-22 04:05PM
Mar-28-22 03:14PM
Mar-25-22 08:30AM
Mar-17-22 08:30AM
Mar-04-22 04:00PM
Mar-02-22 04:05PM
Mar-01-22 03:38PM
Feb-28-22 05:45PM
04:05PM
Feb-24-22 03:49PM
Feb-22-22 04:05PM
Feb-11-22 07:25AM
Feb-07-22 09:38AM
Feb-02-22 01:38PM
Jan-19-22 01:38PM
Jan-03-22 09:38PM
Dec-09-21 04:19PM
12:32PM
10:00AM
08:00AM
Dec-06-21 01:42PM
Nov-18-21 07:30AM
Nov-11-21 04:05PM
Nov-03-21 06:05PM
04:01PM
Oct-28-21 08:30AM
Oct-11-21 10:00AM
Oct-04-21 08:30AM
Sep-21-21 04:05PM
Sep-13-21 07:33PM
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morgan AdamDirectorJul 21Buy1.372,486,7443,406,8396,986,744Jul 25 04:22 PM